|
LPIN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.32747196252603E-15 |
| Normal-vs-Stage2 |
1.47879997136613E-09 |
| Normal-vs-Stage3 |
1.0991207943789E-14 |
| Normal-vs-Stage4 |
1.81166193158333E-12 |
| Stage1-vs-Stage2 |
4.908000E-01 |
| Stage1-vs-Stage3 |
7.707900E-02 |
| Stage1-vs-Stage4 |
3.217700E-02 |
| Stage2-vs-Stage3 |
5.809400E-01 |
| Stage2-vs-Stage4 |
3.656400E-01 |
| Stage3-vs-Stage4 |
6.651800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
8.40120000000777E-05 |
| Normal-vs-Asian |
1.94170000078486E-08 |
| Caucasian-vs-AfricanAmerican |
1.797000E-01 |
| Caucasian-vs-Asian |
5.333000E-01 |
| AfricanAmerican-vs-Asian |
4.405000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05693231944315E-13 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.555000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.82542869708868E-12 |
| Normal-vs-Age(41-60Yrs) |
1.99840144432528E-15 |
| Normal-vs-Age(61-80Yrs) |
1.66477942542542E-12 |
| Normal-vs-Age(81-100Yrs) |
1.003480E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.396400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.401840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.813800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.134000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.845200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.590200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.869700E-02 |
| Classical-VS-Follicular |
7.939200E-03 |
| Classical-VS-Other |
8.014400E-01 |
| Classical-VS-Normal |
1.62614366416847E-12 |
| Tall-VS-Follicular |
9.567200E-01 |
| Tall-VS-Other |
4.627000E-01 |
| Tall-VS-Normal |
1.80780002079217E-09 |
| Follicular-VS-Other |
2.667600E-01 |
| Follicular-VS-Normal |
1.72628578098966E-12 |
| Other-VS-Normal |
2.182100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33226762955019E-14 |
| Normal-vs-N1 |
2.81419998415799E-10 |
| N0-vs-N1 |
8.896400E-01 |
|
|
